Articles related to PROSTATE CANCER

New data suggests that intensifying neoadjuvant therapy with abiraterone or docetaxel could significantly improve outcomes in very high-risk prostate cancer patients. Explore the full findings to consider how this could impact your treatment approach.

This groundbreaking study provides new insights into the risk of prostate cancer in transgender women, emphasizing the need for tailored screening and awareness among healthcare providers.

This study challenges the conventional reliance on BCR as a primary end point in prostate cancer trials, emphasizing the need for a more comprehensive approach that includes overall survival rates.

New research reveals significant differences in overall survival rates based on the site of visceral metastases in metastatic prostate cancer. Discover how these insights could shape your approach to patient care.

Discover how real-world data on 177Lu PSMA validates its efficacy in mCRPC treatment, providing actionable early markers for therapeutic response. Learn how these findings can enhance your clinical decision-making.

New research questions the life-extending efficacy of most common cancer screenings, emphasizing the need for transparent physician-patient discussions to weigh the risks and benefits. Learn more about this crucial topic that might change your approach to recommending screenings.